Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
暂无分享,去创建一个
Clara Bayarri | Victor Amezcua | Clara Bayarri | J. Lorente | J. Valdivia | Jose Antonio Lorente | Carmen Garrido-Navas | Diego de Miguel-Pérez | Jose Exposito-Hernandez | Alba Ortigosa | Javier Valdivia | Rosa Guerrero | Jose Luis Garcia Puche | Maria José Serrano | M. Serrano | V. Amezcua | Carmen Garrido-Navas | J. L. García Puche | J. Expósito-Hernández | Alba Ortigosa | Diego de Miguel-Pérez | Rosa Guerrero
[1] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[2] C. Gerhauser. Impact of dietary gut microbial metabolites on the epigenome , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.
[3] S. Lightfoot,et al. Dclk1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition , 2014, Oncotarget.
[4] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[5] Wenguang Liu,et al. Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation , 2016, Tumor Biology.
[6] P. Mukherjee,et al. Role of Microbiome in Modulating Immune Responses in Cancer , 2019, Mediators of inflammation.
[7] George Coukos,et al. Cancer immunotherapy comes of age , 2011, Nature.
[8] M. Huycke,et al. Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect , 2014, Gut.
[9] H. Yim,et al. Microbial Factors in Inflammatory Diseases and Cancers. , 2017, Advances in experimental medicine and biology.
[10] J. Pollard,et al. Immune cell promotion of metastasis , 2015, Nature Reviews Immunology.
[11] L. Tang,et al. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein , 2014, Nature Communications.
[12] D. Shu,et al. Microbial metabolite butyrate facilitates M2 macrophage polarization and function , 2016, Scientific Reports.
[13] Yingqiu Xie,et al. Role of Yes-associated protein in cancer: An update , 2016, Oncology letters.
[14] P. Zhang,et al. Gut microbiome and cancer immunotherapy. , 2019, Cancer letters.
[15] H. Harmsen,et al. The role of the microbiome for human health: from basic science to clinical applications , 2018, European Journal of Nutrition.
[16] Andreas H. Nuber,et al. Long-lived intestinal tuft cells serve as colon cancer-initiating cells. , 2014, The Journal of clinical investigation.
[17] Lesley M. Chapman,et al. Emerging roles for platelets as immune and inflammatory cells. , 2014, Blood.
[18] P. Traber,et al. Cancer in inflammatory bowel disease. , 1994, The Medical clinics of North America.
[19] K. Peremans,et al. Crosstalk between the microbiome and cancer cells by quorum sensing peptides , 2015, Peptides.
[20] K. D. de Visser,et al. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities , 2018, Disease Models & Mechanisms.
[21] M. Colombo,et al. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. , 2008, Cancer research.
[22] D. Pardoll,et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.
[23] C. Sears,et al. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. , 2014, The Journal of clinical investigation.
[24] C. Logsdon,et al. The immune system in cancer metastasis: friend or foe? , 2017, Journal of Immunotherapy for Cancer.
[25] F. Gao,et al. Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with E-cadherin. , 2018, Oncology letters.
[26] Mingyang Song,et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.
[27] P. Metharom,et al. Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis , 2017, International Journal of Molecular Sciences.
[28] Yongzhi Yang,et al. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. , 2017, Gastroenterology.
[29] Gary An,et al. Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model , 2014, Theoretical Biology and Medical Modelling.
[30] Michael C. Schmid,et al. Macrophages as Key Drivers of Cancer Progression and Metastasis , 2017, Mediators of inflammation.
[31] R. Zamarchi,et al. The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy , 2018, Diagnostics.
[32] J. Lorente,et al. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients , 2018, Journal of Translational Medicine.
[33] J. Italiano,et al. The incredible journey: From megakaryocyte development to platelet formation , 2013, The Journal of cell biology.
[34] G. Gambassi,et al. The Microbiota and Immune System Crosstalk in Health and Disease , 2018, Mediators of inflammation.
[35] D. Xiu,et al. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma , 2016, Medicine.
[36] Nailin Li. Platelets in cancer metastasis: To help the “villain” to do evil , 2016, International journal of cancer.
[37] Yong‐Nyun Kim,et al. Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.
[38] S. Margetić. Inflammation and haemostasis , 2012, Biochemia medica.
[39] Georg Krupitza,et al. Initial steps of metastasis: Cell invasion and endothelial transmigration , 2011, Mutation research.
[40] D. Haber,et al. A conduit to metastasis: circulating tumor cell biology , 2017, Genes & development.
[41] A. Al-Mehdi,et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.
[42] M. Salido,et al. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer , 2014, Oncotarget.
[43] N. Hyman,et al. How the microbiome is shaping our understanding of cancer biology and its treatment , 2017 .
[44] Jian Zhang,et al. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.
[45] K. Miyazono,et al. ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets , 2017, Cell Death and Differentiation.
[46] Ying-Chih Chang,et al. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients , 2016, Scientific Reports.
[47] I. Lizasoain,et al. Neutrophils scan for activated platelets to initiate inflammation , 2014, Science.
[48] R. Cummings,et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin , 1995, The Journal of cell biology.
[49] P. Hofman,et al. Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment , 2019, Cells.
[50] E. Dias-Neto,et al. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. , 2019, The oncologist.
[51] Katarzyna A Rejniak,et al. Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. , 2016, Advances in experimental medicine and biology.
[52] Dariusz Szukiewicz,et al. The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis , 2014, Mediators of inflammation.
[53] O. Reséndis-Antonio,et al. Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine , 2016, Front. Physiol..
[54] A. Moustakas,et al. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β , 2018, International journal of molecular sciences.
[55] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[56] P. Wee,et al. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways , 2017, Cancers.
[57] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[58] P. Godowski,et al. Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses1 , 2003, The Journal of Immunology.
[59] C. Dubois,et al. Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis , 2018, Cancers.
[60] K. M. McSweeney,et al. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases , 2019, Cancer and Metastasis Reviews.
[61] Corrie M. Whisner,et al. The Role of the Microbiome in Cancer Initiation and Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s Growth , 2019, Current Nutrition Reports.
[62] T. Fehm,et al. Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer. , 2013, Anticancer Research.
[63] R. May,et al. Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells , 2016, Journal of carcinogenesis & mutagenesis.
[64] B. Rath,et al. Circulating tumor cell interactions with macrophages: implications for biology and treatment. , 2017, Translational lung cancer research.
[65] Sebastian G Strobel,et al. Cancer in inflammatory bowel disease: lessons from animal models , 2012, Current opinion in gastroenterology.
[66] M. R. Rubinstein,et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.
[67] Jean Paul Thiery,et al. Epithelial-mesenchymal transitions: insights from development , 2012, Development.
[68] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[69] M. Delgado-Rodríguez,et al. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection , 2016, PloS one.